Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy
- 13 November 2009
- journal article
- letter
- Published by Wiley in Muscle & Nerve
- Vol. 41 (2), 286-287
- https://doi.org/10.1002/mus.21560
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- SPORADIC LATE-ONSET NEMALINE MYOPATHY EFFECTIVELY TREATED BY MELPHALAN AND STEM CELL TRANSPLANTNeurology, 2008
- STEM CELL TRANSPLANTATION IN A PATIENT WITH LATE-ONSET NEMALINE MYOPATHY AND GAMMOPATHYNeurology, 2008
- A “nema” of hope in the treatment of late-onset nemaline myopathyNeurology, 2008
- Early treatment‐related mortality in adult autologous stem cell transplant recipients: a nation‐wide survey of 1482 transplanted patientsEuropean Journal of Haematology, 2006
- Adult-Onset Nemaline Myopathy and Monoclonal GammopathyArchives of Neurology, 2006
- Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocolBlood, 2005
- Sporadic late onset nemaline myopathyNeurology, 2005
- History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendationJournal of the Peripheral Nervous System, 2005
- Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophyMuscle & Nerve, 1982